State of the art paper Natural approaches in metabolic syndrome management

  • Rizzo M
  • Patti A
  • Al-Rasadi K
  • et al.
N/ACitations
Citations of this article
22Readers
Mendeley users who have this article in their library.

Abstract

Metabolic syndrome (MetS) is characterized as a group of cardiometabolic risk factors that raise the risk for heart disease and other health problems, such as diabetes mellitus and stroke. Treatment strategies include phar-macologic interventions and supplementary (or "alternative") treatments. Nutraceuticals are derived from food sources (isolated nutrients, dietary supplements and herbal products) that are purported to provide health benefits, in addition to providing basic nutritional value. Nutraceuticals are claimed to prevent chronic diseases, improve health, delay the aging process , increase life expectancy, and support the structure and function of the body. The study of the beneficial effects of nutraceuticals in patients with MetS, including product standardization, duration of supplementation and definition of optimal dosing, could help better define appropriate treatment. This review focuses on widely marketed nutraceuticals (namely polyphenols, omega-3 fatty acids, macroelements and vitamins) with clinically demonstrated effects on more than one component of MetS.

Cite

CITATION STYLE

APA

Rizzo, M., Patti, A. M., Al-Rasadi, K., Giglio, R. V., Nikolic, D., Mannina, C., … Toth, P. P. (2018). State of the art paper Natural approaches in metabolic syndrome management. Arch Med Sci, 14(1), 422–441. Retrieved from https://doi.org/10.5114/aoms.2017.68717

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free